One year after unveiling a timeline for its general surgical robot, Johnson & Johnson (J&J) has submitted an investigational device exemption (IDE) to the US Food and Drug Administration (FDA) as it eyes initiating clinical trials.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,